Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR C-type lectin domain family 4 member C inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lupus Erythematosus, Systemic 3 D008180 ClinicalTrials
Lupus Erythematosus, Cutaneous 2 D008178 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3833308